Year: 2015
Type: article
Abstract: In addition to their stem/progenitor properties, mesenchymal stem cells (MSCs) also exhibit potent effector (angiogenic, antiinflammatory, immuno-modulatory) functions that are largely paracrine in nature. It is widely believed that effector functions underlie most of the therapeutic potential of MSCs and are independent of their stem/progenitor properties. Here we demonstrate that stem/progenitor and effector functions are coordinately regulated at the cellular level by the transcription factor Twist1 and specified within populations according to a hierarchical model. We further show that manipulation of Twist1 levels by genetic approaches or by exposure to widely used culture supplements including fibroblast growth factor 2 (Ffg2) and interferon gamma (IFN-gamma) alters MSC efficacy in cell-based and in vivo assays in a predictable manner. Thus, by mechanistically linking stem/progenitor and effector functions our studies provide a unifying framework in the form of an MSC hierarchy that models the functional complexity of populations. Using this framework, we developed a CLinical Indications Prediction (CLIP) scale that predicts how donor-to-donor heterogeneity and culture conditions impact the therapeutic efficacy of MSC populations for different disease indications.
Source: EBioMedicine
Authors: Siddaraju V. Boregowda(Conceptualization, Formal analysis, Investigation, Validation, Writing – original draft, Writing – review & editing), Veena Krishnappa(Formal analysis, Investigation, Validation), Christopher L. Haga(Investigation, Validation), Luis A. Ortiz(Investigation, Writing – review & editing), Donald G. Phinney(Conceptualization, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Scripps Research Institute, University of Pittsburgh
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,780
OpenAlex ID: W2197331811
